Jim Cramer Says He Blessed MannKind as a Speculation Only

MannKind Corporation (NASDAQ:MNKD) was among the stocks Jim Cramer highlighted on Mad Money as he noted that the market has an appetite for stocks. Answering a caller’s query about the stock during the lightning round, Cramer stated:

100% speculation, a total speculation. In my book, I talk about how you can have one speculation, and then you have to have other stocks that are, you know, considered to be a little bit more earnings-oriented. This would fit as that speculation, so I blessed it for that purpose only.

Photo by Artem Podrez on Pexels

MannKind Corporation (NASDAQ:MNKD) is a biopharmaceutical company that develops and commercializes inhaled therapies, wearable delivery devices, and injectable treatments to manage chronic conditions like diabetes, pulmonary hypertension, and fluid overload.

While we acknowledge the risk and potential of MNKD as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. If you are looking for an AI stock that is more promising than MNKD and that has 10,000% upside potential, check out our report about this cheapest AI stock.

READ NEXT: 33 Stocks That Should Double in 3 Years and 15 Stocks That Will Make You Rich in 10 Years 

Disclosure: None. Follow Insider Monkey on Google News.

1281292 - 11759070 - 1